FYVIMGO Trademark

Trademark Overview


On Friday, February 11, 2022, a trademark application was filed for FYVIMGO with the United States Patent and Trademark Office. The USPTO has given the FYVIMGO trademark a serial number of 97251147. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, February 15, 2024. This trademark is owned by GlaxoSmithKline Biologicals SA. The FYVIMGO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines
fyvimgo

General Information


Serial Number97251147
Word MarkFYVIMGO
Filing DateFriday, February 11, 2022
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, February 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxoSmithKline Biologicals SA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRixensart B-1330
BE

Trademark Events


Event DateEvent Description
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, February 12, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 22, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 19, 2024ASSIGNED TO LIE
Wednesday, August 30, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, May 30, 2023NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, May 30, 2023INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 30, 2023SUSPENSION INQUIRY WRITTEN
Monday, May 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, November 16, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, November 16, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, November 16, 2022SUSPENSION LETTER WRITTEN
Tuesday, November 15, 2022ASSIGNED TO EXAMINER
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 15, 2022NEW APPLICATION ENTERED